Fabrizio Giannotta
Keine laufenden Positionen mehr
Karriereverlauf von Fabrizio Giannotta
Ehemalige bekannte Positionen von Fabrizio Giannotta
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ProGenosis SA
 ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Vorstandsvorsitzender | 29.06.2006 | - |
| Gründer | 02.11.2009 | - |
Ausbildung von Fabrizio Giannotta
| University of Liege | Doctorate Degree |
Statistik
International
| Belgien | 3 |
Operativ
| Chief Executive Officer | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ProGenosis SA
ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Health Technology |
- Börse
- Insiders
- Fabrizio Giannotta
- Erfahrung
